- Home
- PMN vs CLPS Comparison
PMN vs CLPS Comparison
Compare PMN & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMN
- CLPS
- Stock Information
- Founded
- PMN 2004
- CLPS 2005
- Country
- PMN Canada
- CLPS Hong Kong
- Employees
- PMN N/A
- CLPS N/A
- Industry
- PMN Pharmaceuticals and Biotechnology
- CLPS Computer Software: Prepackaged Software
- Sector
- PMN Health Care
- CLPS Technology
- Exchange
- PMN Nasdaq
- CLPS Nasdaq
- Market Cap
- PMN 29.8M
- CLPS 35.1M
- IPO Year
- PMN N/A
- CLPS 2018
- Fundamental
- Price
- PMN $0.82
- CLPS $1.27
- Analyst Decision
- PMN
- CLPS
- Analyst Count
- PMN 0
- CLPS 0
- Target Price
- PMN N/A
- CLPS N/A
- AVG Volume (30 Days)
- PMN 44.3K
- CLPS 24.5K
- Earning Date
- PMN 03-31-2025
- CLPS 03-04-2025
- Dividend Yield
- PMN N/A
- CLPS 10.24%
- EPS Growth
- PMN N/A
- CLPS N/A
- EPS
- PMN N/A
- CLPS N/A
- Revenue
- PMN N/A
- CLPS $142,812,726.00
- Revenue This Year
- PMN N/A
- CLPS N/A
- Revenue Next Year
- PMN N/A
- CLPS N/A
- P/E Ratio
- PMN N/A
- CLPS N/A
- Revenue Growth
- PMN N/A
- CLPS N/A
- 52 Week Low
- PMN $0.80
- CLPS $0.68
- 52 Week High
- PMN $2.61
- CLPS $1.70
- Technical
- Relative Strength Index (RSI)
- PMN 36.19
- CLPS 50.44
- Support Level
- PMN $0.81
- CLPS $1.19
- Resistance Level
- PMN $0.94
- CLPS $1.36
- Average True Range (ATR)
- PMN 0.07
- CLPS 0.09
- MACD
- PMN -0.01
- CLPS -0.00
- Stochastic Oscillator
- PMN 6.07
- CLPS 47.37
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.